The Liver as an Endocrine Organ: Hormone Production, Activation and Systemic Metabolic Regulation
Although widely recognised for its metabolic, detoxification and synthetic roles, the liver also functions as a key endocrine organ. It produces, activates and regulates several hormones essential for growth, metabolism, iron balance, blood pressure and reproductive function. Acting at the intersection of nutrition and endocrine physiology, the liver translates nutrient availability and metabolic demands into coordinated hormonal responses. These endocrine actions influence nearly all major body systems and highlight the liver’s central role in maintaining physiological stability.
What You Need to Know
Although the liver is not a classical endocrine gland, it plays a central endocrine role by producing hormones, activating circulating precursors, and synthesising carrier proteins that determine hormone availability and action. Through these functions, the liver integrates metabolism, growth, iron balance, blood pressure regulation, and endocrine signalling across multiple organ systems. Disruption of hepatic function therefore has widespread hormonal consequences that extend far beyond digestion and detoxification.
One of the liver’s most important endocrine roles is the production of insulin-like growth factor-1 (IGF-1), which mediates many of the growth-promoting and anabolic effects of growth hormone. The liver also synthesises angiotensinogen, the precursor of angiotensin II, placing it upstream of the renin–angiotensin–aldosterone system and making it a key contributor to blood pressure and volume regulation. In addition, the liver produces hepcidin, the master regulator of systemic iron homeostasis, which controls intestinal iron absorption and iron release from macrophages and hepatocytes.
In parallel, the liver modifies and regulates circulating hormones through activation, conversion, and transport, including:
activation of vitamin D into its biologically active intermediate
conversion of thyroid hormone T4 into the more active T3
synthesis of binding proteins such as albumin and hormone-binding globulins that regulate free hormone availability
Because so many endocrine pathways depend on normal hepatic function, liver disease frequently produces secondary hormonal disturbances. Reduced IGF-1 contributes to muscle wasting and impaired growth, altered angiotensinogen production affects blood pressure regulation, and disordered hepcidin signalling leads to iron overload or deficiency. Understanding the liver as an endocrine organ is therefore essential for interpreting the systemic manifestations of hepatic disease and appreciating its central role in metabolic and hormonal homeostasis.
Beyond the Basics
IGF-1: growth hormone’s peripheral effector
IGF-1 is produced primarily by hepatocytes in response to growth hormone stimulation and serves as the principal mediator of GH’s growth-promoting effects. By stimulating cellular proliferation, protein synthesis, and longitudinal bone growth, IGF-1 is essential for normal childhood development and for ongoing tissue maintenance and repair in adults. Unlike GH, which is secreted in pulsatile bursts, IGF-1 circulates at relatively stable concentrations, making it a more reliable marker of integrated GH activity over time.
IGF-1 also contributes to endocrine feedback regulation by acting on both the hypothalamus and anterior pituitary to suppress further GH release. When IGF-1 levels are reduced, as occurs in malnutrition, chronic inflammatory disease, or hepatic dysfunction, anabolic capacity is impaired. In children this manifests as growth failure, while in adults it contributes to sarcopenia, fatigue, and impaired tissue repair.
Angiotensinogen and blood pressure regulation
Angiotensinogen is synthesised almost exclusively by the liver and released continuously into the circulation, where it serves as the substrate for renin. Cleavage of angiotensinogen initiates the renin–angiotensin–aldosterone system, ultimately generating angiotensin II, one of the body’s most potent regulators of vascular tone and sodium balance. Through this upstream position, the liver exerts indirect but essential control over blood pressure and extracellular fluid volume.
Angiotensinogen production is dynamically regulated rather than fixed. Levels rise during inflammation, pregnancy, and oestrogen exposure, amplifying downstream RAAS activity. This helps explain why systemic inflammatory states and pregnancy are associated with altered blood pressure regulation and why liver disease can destabilise circulatory homeostasis even in the absence of primary vascular pathology.
Hepcidin: master regulator of iron metabolism
Hepcidin is a peptide hormone produced by hepatocytes that functions as the central regulator of systemic iron balance. It controls iron availability by binding to ferroportin, the iron export channel expressed on enterocytes, macrophages, and hepatocytes, causing its internalisation and degradation. When hepcidin levels are elevated, intestinal iron absorption falls and iron becomes sequestered within storage sites.
Hepcidin production increases in response to inflammation and infection as part of the innate immune response, limiting iron availability to pathogens. This mechanism underlies the anaemia of chronic disease. In contrast, inadequate hepcidin activity permits excessive iron absorption and progressive tissue deposition, as seen in hereditary haemochromatosis, leading to liver injury, diabetes, cardiomyopathy, and endocrine dysfunction.
Hormone activation: vitamin D and thyroid hormone
The liver plays a critical role in endocrine regulation through hormone activation rather than direct secretion. It converts vitamin D into 25-hydroxyvitamin D, the major circulating form used to assess vitamin D status. Without this hepatic step, subsequent renal conversion to active calcitriol cannot occur, impairing calcium and phosphate homeostasis.
The liver also participates in thyroid hormone metabolism by converting thyroxine (T4) into either the active hormone triiodothyronine (T3) or inactive reverse T3. These conversions allow metabolic rate to be adjusted during illness, fasting, or physiological stress, illustrating how hepatic metabolism fine-tunes endocrine signalling at a systemic level.
Synthesis of hormone-binding proteins
The liver synthesises plasma proteins that transport hormones and regulate their bioavailability, including:
sex hormone–binding globulin (SHBG)
thyroxine-binding globulin (TBG)
corticosteroid-binding globulin (CBG)
albumin, which carries numerous hormones and drugs
Changes in liver function alter the concentration of these binding proteins, affecting total hormone levels without necessarily changing free, biologically active hormone. This is why endocrine test interpretation in liver disease requires assessment of binding status rather than reliance on total hormone concentrations alone.
Glucose and lipid regulation through endocrine integration
Although the liver does not produce insulin or glucagon, it is their principal target organ and therefore a critical endocrine integrator. In response to insulin, the liver promotes glycogen synthesis and lipid storage. In response to glucagon and catecholamines, it increases glycogenolysis, gluconeogenesis, and lipid mobilisation.
Through this responsiveness, the liver coordinates metabolic transitions between fed and fasting states, maintains blood glucose stability, and integrates hormonal signals with nutrient availability. Liver dysfunction therefore disrupts not only metabolism itself but also the effectiveness of endocrine control across the entire organism.
Clinical Connections
Liver disease produces wide-ranging endocrine consequences because the liver sits upstream of multiple hormonal pathways rather than acting as a passive metabolic organ. When hepatic function declines, hormone production, activation, transport, and signalling are all affected simultaneously, which explains why endocrine abnormalities are common even when primary endocrine glands are structurally normal.
Clinically, disruption of hepatic endocrine function produces a characteristic pattern of findings:
reduced IGF-1 production, leading to impaired growth in children and muscle wasting, frailty, and reduced anabolic capacity in adults
impaired vitamin D activation and altered thyroid hormone conversion, contributing to osteoporosis, sarcopenia, and metabolic instability
inflammation-driven increases in hepcidin, resulting in iron sequestration and anaemia of chronic disease
reduced synthesis of hormone-binding proteins, causing abnormal total hormone levels despite normal free hormone activity
In chronic liver disease and cirrhosis, these mechanisms often coexist. Patients may appear biochemically hypothyroid, hypogonadal, or cortisol-deficient despite intact endocrine glands, because altered binding proteins and hepatic conversion distort standard hormone assays. This makes interpretation of endocrine tests particularly challenging in liver disease and highlights the importance of assessing free hormone levels and overall clinical context.
Disorders such as haemochromatosis, systemic hypertension, insulin resistance, and metabolic syndrome further illustrate the liver’s endocrine influence. In these conditions, dysregulated hepatic signalling contributes directly to iron overload, vascular dysfunction, and impaired metabolic control. Understanding the liver as an endocrine organ is therefore essential for recognising secondary hormonal disturbances and avoiding misdiagnosis of primary endocrine disease in patients with hepatic pathology.
Concept Check
How does the liver integrate with growth hormone to regulate tissue growth?
Why is the liver essential for the activation of vitamin D?
What is the role of hepcidin in iron homeostasis?
How does hepatic production of angiotensinogen influence blood pressure?
Why do liver disorders cause abnormalities in circulating hormone levels even when endocrine glands are functioning normally?